Related Experiment Videos
[Status of interferon in genital infections]
Insights
This study evaluated interferon (IFN) production in women with genital infections using fetal calf serum and autologous sera. Results show autologous sera can inhibit or stimulate IFN-gamma and contain IFN-alpha, impacting therapy.
Area of Science:
- Immunology
- Virology
- Microbiology
Context:
- Genital infections are common and can impact immune function.
- Assessing interferon (IFN) system function is crucial for understanding immune response.
- Current methods for evaluating IFN production may not fully reflect in vivo conditions.
Purpose:
- To evaluate the functional activity of the interferon (IFN) system in patients with genital infections.
- To compare the capacity of leukocytes to produce IFN-alpha and IFN-gamma using fetal calf serum (FCS) versus autologous sera.
- To investigate the influence of autologous sera on IFN production in the context of specific genital infections.
Summary:
- Leukocyte samples from 30 women with genital infections (herpes simplex virus, cytomegalovirus, Chlamydia, Ureaplasma) were tested for IFN-alpha and IFN-gamma production.
- Autologous sera inhibited IFN-gamma production in 40% of patients and stimulated it in 6.6%, compared to FCS.
- Acid-labile IFN-alpha was detected in 20.3% of autologous sera, with statistically reliable data.
Impact:
- Findings suggest that autologous sera can modulate IFN production, offering insights into patient-specific immune responses.
- The results highlight the potential for using autologous sera in interferon status testing for more accurate immune assessment.
- This research can inform the development of more effective immunocorrective therapies for genital infections.
Abstract:
The interferon status test characterizes the interferon (IFN) system function and the functional activity of IFN-producing cytokine cells. In contrast to the routine method, we used fetal calf (FCS) and autologous sera for evaluating the patients' leukocyte capacity to produce IFN-alpha and IFN-gamma. Blood samples from 30 women with genital infections caused by herpes simplex virus, cytomegalovirus, Chlamydia, and Ureaplasma were tested. Autologous sera of 40% patients inhibited and of 6.6% patients stimulated the production of IFN-gamma in comparison with FCS. All the data are statistically reliable. 20.3% autologous sera contained acid-labile IFN-alpha. These results can be used for more effective immunocorrective therapy.